JESSA BONAVIA: Open Payments
NPI 1780365205 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 19 payments from 7 companies in 2025. Trend: 2023 $244 · 2024 $318 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $285 |
| Teva Pharmaceuticals USA, Inc. | 1 | $121 |
| ACADIA Pharmaceuticals Inc | 2 | $115 |
| ABBVIE INC. | 1 | $112 |
| Braeburn Inc. | 3 | $66 |
| Janssen Scientific Affairs, LLC | 1 | $41 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
Products named: REXULTI, AUSTEDO XR, NUPLAZID, VRAYLAR, BRIXADI, INVEGA SUSTENNA, INGREZZA.
Industry payments across FL — which companies pay providers there.
